Genomics in Oncology lecture series invites Myron Best, MD/PhD Student at VUmc Cancer Center in Amsterdam, The Netherlands. Myron shares the team’s latest liquid biopsy research results exploiting tumor-educated platelets as an RNA biosource for future cancer diagnostics and his perspective on the potential impact of genomic technologies in early detection of cancer. Learn more about Genomics in Oncology, visit our website here.
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015.
Subscribe to the Illumina video channel